CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.930
+0.360 (10.08%)
At close: Nov 3, 2025, 4:00 PM EST
4.080
+0.150 (3.82%)
After-hours: Nov 3, 2025, 7:49 PM EST
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $648.11 million as of November 3, 2025. Its market cap has increased by 602.94% in one year.
Market Cap
648.11M
Enterprise Value
496.91M
1-Year Change
602.94%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $464.70M to $648.11M, an increase of 39.47%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 588.70M | 630.40% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
| Oct 8, 2015 | 464.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |